Glyc news
WebJune 13 2016 - 09:00AM. Business Wire. GlycoMimetics, Inc. (NASDAQ:GLYC) today announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its novel E-selectin antagonist GMI-1271 for treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) and elderly patients … WebJan 23, 2024 · GlycoMimetics Inc (GLYC) stock is trading at $2.77 as of 11:07 AM on Monday, Jan 23, a rise of $0.21, or 8.01% from the previous closing price of $2.56. The stock has traded between $2.60 and $2.78 so far today. Volume today is below average.
Glyc news
Did you know?
Web12 hours ago · Dublin, April 14, 2024 (GLOBE NEWSWIRE) -- The "global glycomics market: analysis by product, by application, by end-user, by region size and trends with impact of covid-19 and forecast up to 2028 ... WebApr 6, 2024 · In 2024, GlycoMimetics's revenue was $75,000, a decrease of -93.53% compared to the previous year's $1.16 million. Losses were -$46.69 million, -26.39% less than in 2024. Analyst Forecast According to 9 analysts, the average rating for …
WebGLYC Stock Summary With a price/sales ratio of 786.71, GLYCOMIMETICS INC has a higher such ratio than 99.42% of stocks in our set. As for revenue growth, note that GLYC's revenue has grown -92.9% over the past 12 months; that beats the revenue growth of merely 1.17% of US companies in our set.
WebFeb 15, 2024 · Feb. 15, 2024, 11:25 AM. In a report released today, Edward White from H.C. Wainwright reiterated a Buy rating on GlycoMimetics ( GLYC – Research Report ), … WebGlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2024 Earnings Call Transcript March 29, 2024 Operator: Good morning. And thank you for joining the GlycoMimetics Fourth Quarter …
WebApr 7, 2024 · The data shows that as of Jan 30, 2024 short interest in GlycoMimetics Inc. (GLYC) stood at 1.89% of shares outstanding, with shares short rising to 0.61 million registered in Dec 29, 2024. Current price change has pushed the stock -58.09% YTD, which shows the potential for further growth is there.
WebMar 15, 2024 · Get the latest GlycoMimetics Inc. (GLYC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. chronowear qsw-01hWebDec 12, 2024 · December 12, 2024 - 7:00 am. ROCKVILLE, Md. GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced results from two investigator-sponsored trials studying uproleselan in patients with acute … chronowear 2 qsw-02h sgWebFeb 16, 2024 · GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on February 10, 2024 of a non-qualified stock option award to purchase an aggregate of 150,000 shares to Chinmaya Rath, the Company’s new Senior Vice President and Chief … chronowear liteWebLATEST NEWS. Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico. March 1, 2024-News. Posted by glycotest. 1 MIN READ. Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent. dermatology and skin care associates mason ohWebFind the latest GlycoMimetics, Inc. (GLYC) stock quote, history, news and other vital information to help you with your stock trading and investing. dermatology and skin cancer of kingmanWebApr 6, 2024 · Get GlycoMimetics Inc (GLYC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. dermatology and skin institute of north texasWebGLYC. SIVB. Market News GlycoMimetics Plunges on New Stock Offering. 2M ago. GLYC. The Fly GlycoMimetics price target lowered to $8 from $13 at H.C. Wainwright. 2M ago. GLYC. The Fly GlycoMimetics:Uproleselan in RR … dermatology and skin care arts